跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
UPSTAZA 2,8 × 10E11 GENOMAS VECTORIALES (VG)/0,5 ML PARA SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
UPSTAZA 2,8 × 10E11 GENOMAS VECTORIALES (VG)/0,5 ML PARA SOLUCION PARA PERFUSION
Approved
STANDARD
UPSTAZA 2,8 × 10E11 GENOMAS VECTORIALES (VG)/0,5 ML PARA SOLUCION PARA PERFUSION
Ptc Therapeutics International Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 22, 2022
Approval ID
d145d053adb39429
Company
Ptc Therapeutics International Limited
Type
Standard
Approval Details
Approval Id
d145d053adb39429
Drug Cima Aemps Name
UPSTAZA 2,8 × 10E11 GENOMAS VECTORIALES (VG)/0,5 ML PARA SOLUCION PARA PERFUSION
Register Number
1221653001
Holder Company Name
Ptc Therapeutics International Limited
Marketing Company Name
Ptc Therapeutics International Limited
Holder Company Detail Path
/organization/ptc-therapeutics-international-limited
Marketing Company Detail Path
/organization/ptc-therapeutics-international-limited
Authorization Date
2022-12-22
Dosage Form
SOLUCIÓN PARA PERFUSIÓN
Dose
2,8 x 10e11 vg/0,5 ml
Route Of Administration
USO INTRAPUTAMINAL
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Ptc Therapeutics International Limited
Company Detail Path
/organization/ptc-therapeutics-international-limited
Company Information
Pharmaceutical Company Name
PTC THERAPEUTICS INTERNATIONAL LIMITED
Country Name
Ireland
City Name
dublin,country_ie
Address
5th Floor, 3 Grand Canal Plaza
Active Ingredients
ELADOCAGEN EXUPARVOVEC
5,6 10e11 vg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 22, 2022
Approval ID
d145d053adb39429
Type
Standard
Back to CIMA-AEMPS Approvals